IPP Bureau
$22 million BARDA project taps ProteoNic Tech to boost life-saving monoclonal antibody manufacturing
By IPP Bureau - December 12, 2025
The multi-partner team will integrate new technologies across the entire mAb production workflow, from cell line development to purification
Bristol Myers Squibb scores FDA priority review for Opdivo in advanced hodgkin lymphoma
By IPP Bureau - December 12, 2025
The FDA aims to make a decision by April 8, 2026
Eli Lilly’s retatrutide delivers breakthrough results in obesity & knee osteoarthritis trial
By IPP Bureau - December 12, 2025
Retatrutide, tested at 9 mg and 12 mg doses alongside diet and exercise, met all primary and key secondary endpoints
Dr Agarwals Eye Hospital expands global footprint with advanced centre in Mauritius
By IPP Bureau - December 12, 2025
The new centre brings advanced corneal procedures pioneered in India
Roche bags CE Mark for automated mass spectrometry antibiotics monitoring
By IPP Bureau - December 12, 2025
The cobas Mass Spec solution Ionify reagent portfolio now covers therapeutic drug monitoring for immunosuppressants and antibiotics
FDA nods spotlight precision oncology platforms as market surges towards $212 billion by 2034
By IPP Bureau - December 12, 2025
The U.S. oncology market is projected to soar from $81 billion in 2025 to $212 billion by 2034
OTR Therapeutics and Zealand Pharma join forces to target metabolic diseases
By IPP Bureau - December 12, 2025
The companies aim to expand treatment options for millions living with metabolic disorders
Formation Bio snaps up global rights to next-gen CNS TYK2 inhibitor from Lynk Pharma
By IPP Bureau - December 12, 2025
LNK01006 is designed to deliver potent, selective inhibition of TYK2-mediated cytokine signaling with central nervous system exposure
New oral SERD from Roche delivers significant survival edge in early breast cancer
By IPP Bureau - December 12, 2025
At the trial’s pre-specified interim analysis, giredestrant achieved a hazard ratio of 0.70, marking a statistically significant improvement in invasive disease-free survival
Lupin Manufacturing Solutions partners with PolyPeptide to scale global peptide supply chain
By IPP Bureau - December 12, 2025
This partnership strengthens LMS as a leading CDMO supplier of peptide materials for both innovator and generic markets
Shilpa Medicare receives initial authorization for Rotigotine transdermal patch from Europe
By IPP Bureau - December 12, 2025
This is the first approval of a prescription transdermal dosage Form in the European markets from this facility
Granules India receives official 2025 CDP rating
By IPP Bureau - December 12, 2025
The company had achieved the highest "A" rating in Climate Change
Dr. Reddy's Laboratories announces SBTi targets
By IPP Bureau - December 12, 2025
Dr. Reddy's commits to achieving Net Zero greenhouse gas emissions across its value chain by FY 2045
Senores Pharmaceuticals launches of Deferiprone Tablets USP, 500 mg & 1000 mg
By IPP Bureau - December 12, 2025
The product will be marketed by Dr. Reddy's Laboratories Inc.
Granules Life Sciences facility receives EIR from USFDA
By IPP Bureau - December 12, 2025
This approval confirms the facility's compliance with FDA quality standards and regulatory requirements
